Fipronil ± (S)-Methoprene, Topical

Verify with FDA CVM →

30 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
30
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Fipronil ± (S)-Methoprene, Topical

Administration Routes

Topical

Species Affected

Dog 30

Most Affected Breeds

Crossbred Canine/dog 13
Siberian Husky 6
Retriever - Labrador 5
Setter - Gordon 4
Terrier - West Highland White 1
Dachshund - Miniature 1

Most Reported Reactions

Vomiting 5
Hypoglycaemia 3
Polydipsia 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Sleep disturbance NOS 2
Inappropriate urination 2
Decreased appetite 2
Cataract 2
Uncoded sign 1
Dermatosis NOS 1
Pyoderma 1
Papular rash 1

Outcome Breakdown

Recovered/Normal
24 (80.0%)
Ongoing
3 (10.0%)
Outcome Unknown
2 (6.7%)
Recovered with Sequela
1 (3.3%)

Data Summary

Metric Value
Total adverse event reports 30
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 1
Distinct breeds in reports 6
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Fipronil ± (S)-Methoprene, Topical Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 30 adverse event reports referencing Fipronil ± (S)-Methoprene, Topical, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Fipronil ± (S)-Methoprene, Topical. Reported administration route is Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Fipronil ± (S)-Methoprene, Topical reports are Dog (30 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (13), Siberian Husky (6), Retriever - Labrador (5) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Fipronil ± (S)-Methoprene, Topical are Vomiting (5), Hypoglycaemia (3), Polydipsia (2), Lethargy (see also Central nervous system depression in 'Neurological') (2). Of the 30 reports with a coded outcome, Recovered/Normal is the leading category at 80.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Fipronil ± (S)-Methoprene, Topical.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial